Vitamin Angels teams up with ‘Life…supplemented’
WASHINGTON The Council for Responsible Nutrition’s “Life…supplemented” campaign on Monday announced plans to partner with international charity Vitamin Angels, an organization dedicated to bringing essential nutrition to children around the world through vitamins.
The partnership is part of the campaign’s America’s Wellness Challenge initiative, designed to motivate people to take simple lifestyle steps within the three pillars of health and includes a sweepstakes offering consumers the chance to win $15,000. For every consumer who enters America’s Wellness Challenge, and takes the free online questionnaire My Wellness Scorecard, the “Life…supplemented” campaign will donate $1, up to $10,000, to Vitamin Angels.
“Our goal is to provide malnourished children across the globe with the vital nutrients they desperately need for good health,” stated Howard Schiffer, president of Vitamin Angels. “Vitamins save lives — this donation from the ‘Life…supplemented’ program will help us continue our mission of bringing important vitamins to impoverished children so they have an opportunity to lead more productive lives.”
The contribution will be made as part of the campaign’s dedicated focus on reaching its consumers via social media channels. Vitamin Angels, which also has an active social media presence, and the “Life…supplemented” campaign together will connect with consumers via online social communities, as well through their respective Web sites. You can follow “Life…supplemented” on Twitter under wannaBwell, and find updates to the campaign via Facebook. Additionally, Vitamin Angels can be found on Twitter, Facebook and a variety of other on-line social communities.
“We know that everyday more consumers head to online channels for specific information on health and wellness, and the ‘Life…supplemented’ campaign recognizes the importance of being accessible in these on-ine spaces,” stated Judy Blatman, SVP, CRN. “We’re excited to extend our reach into these communities, and look forward to fostering deeper relationships with consumers who have a vested interest in overall wellness through the use of healthy diet, supplements and exercise.”
Decision Resources projects same U.S., Europe patient share of ulcerative colitis biologic
WALTHAM, Mass. A new report by Decision Resources revealed that a biological therapy with a mechanism of action other than tumor necrosis factor-alpha inhibitors, used for the treatment of moderate to severe ulcerative colitis, would earn a 25% patient share in both the United States and Europe.
The report, “Ulcerative Colitis: Gastroenterologists Identify Emerging Drugs That Will Challenge the Benchmark Therapy Infliximab for Moderate to Severe UC,” finds that two emerging TNF-alpha inhibitors — Abbott/Eisai’s Humira and Centocor Ortho Biotech/Merck/Mitsubishi Tanabe Pharma/Janssen’s Simponi — will earn Decision Resources’ proprietary clinical gold standard status for ulcerative colitis in 2013 following their approval for the indication. Both Humira and Simponi have competitive advantages over sales-leader Remicade in efficacy, delivery, and safety and tolerability.
“Although clinical trial data are limited, interviewed experts believe that both Humira and Simponi’s fully human composition will translate into incremental advantages in efficacy for maintenance of remission and maintenance of response compared to Remicade, which is a chimeric monoclonal antibody,” said Decision Resources analyst Kathryn Benton.
HHS debuts H1N1 vaccine ad during football games
WASHINGTON The Department of Health and Human Services is continuing to advocate getting the H1N1 influenza vaccine, even this late into the season, as the agency announced last week the launch of a new H1N1 flu vaccination advertisement that aired during four college football bowl games held over the New Year’s holiday.
The ad is aimed at encouraging young people and all Americans to get vaccinated against the H1N1 flu.
“Young Americans have been especially hard hit by the 2009 H1N1 flu,” stated HHS secretary Sebelius. “Sports events are important opportunities to encourage fans, athletes, young adults and all Americans to protect themselves by getting the H1N1 vaccine. We hope that college athletic teams across the country will continue to join us in the fight against the H1N1 flu by getting vaccinated and encouraging others to get vaccinated too.”
With more than 110 million doses of the 2009 H1N1 vaccine now available, “all Americans are encouraged to get vaccinated and protect themselves and their loved ones during flu season, which typically lasts from October until May,” the agency stated.
For the week ended Dec. 26, rates of reported influenza-like illnesses continued to decline, though nationwide ILI incidence is still higher than is typical for this time of the year.